Autoimmune hemolytic anemia secondary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Irfan Dotani
Overview
There is no significant role for secondary prevention of autoimmune hemolytic anemia.
Secondary Prevention
- There is no role for secondary prevention of autoimmune hemolytic anemia.
- However, in patients at risk for hemolytic anemia who are suspected of having active hemolysis, screening for active hemolysis can be done via assessment of complete blood count (CBC), lactate dehydrogenase (LDH), total bilirubin, and reticulocyte count.[1]
References
- ↑ Zanella A, Barcellini W (2014). “Treatment of autoimmune hemolytic anemias”. Haematologica. 99 (10): 1547–54. doi:10.3324/haematol.2014.114561. PMC 4181250. PMID 25271314.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH